The article really focuses on pharma versus hospitals. But it fails to mention that state and county health departments across the nation use 340B program to provide free medications of public health importance to the public.
-
-
- 1 more reply
New conversation -
-
-
Maybe this is too far into the weeds even for you guys, but I’d read an article about the administrative costs of 340B - tracking accumulations, audits, etc. There are businesses that only exist to help you comply with 340B, which adds to the list of interested parties.
-
That’s the one thing I can’t square with the idea that 340B is the side show to drug prices - orgs are willing to spend a lot of resources on doing 340B, and companies spend a ton to fight back, which makes the stakes look really high for 340B.
-
Or maybe what it just means is that if the fight over 340B is this big, the fight over overall price controls would be insane.
End of conversation
New conversation -
-
-
Point missed: fight is that hospital gets drugs at 26-50% discount while still receiving full reimbursement (avg. price +6%) from gov’t. No restrictions or reporting requirements on the use of government funded windfall to treat low-income patients.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
My mom works at a hemophilia treatment center and their program lives or dies by 340b.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.